TROW
Price
$100.15
Change
+$0.19 (+0.19%)
Updated
Jul 3 closing price
Capitalization
26.92B
27 days until earnings call
VERA
Price
$23.65
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
1.53B
32 days until earnings call
Interact to see
Advertisement

TROW vs VERA

Header iconTROW vs VERA Comparison
Open Charts TROW vs VERABanner chart's image
T Rowe Price Group
Price$100.15
Change+$0.19 (+0.19%)
Volume$924.24K
Capitalization26.92B
Vera Therapeutics
Price$23.65
Change-$0.00 (-0.00%)
Volume$1.19K
Capitalization1.53B
TROW vs VERA Comparison Chart in %
Loading...
TROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TROW vs. VERA commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TROW is a StrongBuy and VERA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (TROW: $100.15 vs. VERA: $23.65)
Brand notoriety: TROW and VERA are both not notable
TROW represents the Investment Managers, while VERA is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: TROW: 62% vs. VERA: 0%
Market capitalization -- TROW: $26.92B vs. VERA: $1.53B
TROW [@Investment Managers] is valued at $26.92B. VERA’s [@Biotechnology] market capitalization is $1.53B. The market cap for tickers in the [@Investment Managers] industry ranges from $124.17B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $118.03B to $0. The average market capitalization across the [@Investment Managers] industry is $6.16B. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TROW’s FA Score shows that 1 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • TROW’s FA Score: 1 green, 4 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, TROW is a better buy in the long-term than VERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TROW’s TA Score shows that 4 TA indicator(s) are bullish while VERA’s TA Score has 4 bullish TA indicator(s).

  • TROW’s TA Score: 4 bullish, 4 bearish.
  • VERA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TROW is a better buy in the short-term than VERA.

Price Growth

TROW (@Investment Managers) experienced а +4.13% price change this week, while VERA (@Biotechnology) price change was +1.55% for the same time period.

The average weekly price growth across all stocks in the @Investment Managers industry was +2.17%. For the same industry, the average monthly price growth was +6.54%, and the average quarterly price growth was +10.33%.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

TROW is expected to report earnings on Oct 23, 2025.

VERA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Investment Managers (+2.17% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TROW($26.9B) has a higher market cap than VERA($1.53B). TROW YTD gains are higher at: -8.981 vs. VERA (-44.077). TROW has higher annual earnings (EBITDA): 2.52B vs. VERA (-167.77M). TROW has more cash in the bank: 2.07B vs. VERA (590M). VERA has less debt than TROW: VERA (54.5M) vs TROW (308M). TROW has higher revenues than VERA: TROW (6.46B) vs VERA (0).
TROWVERATROW / VERA
Capitalization26.9B1.53B1,757%
EBITDA2.52B-167.77M-1,502%
Gain YTD-8.981-44.07720%
P/E Ratio15.51N/A-
Revenue6.46B0-
Total Cash2.07B590M350%
Total Debt308M54.5M565%
FUNDAMENTALS RATINGS
TROW: Fundamental Ratings
TROW
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
46
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TROWVERA
RSI
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
64%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 23 days ago
64%
Bearish Trend 9 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
52%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
TROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJFQX76.030.98
+1.31%
PGIM Jennison Growth R6
JMCVX16.100.07
+0.44%
Janus Henderson Mid Cap Value T
LSHAX31.230.11
+0.35%
Kinetics Spin-Off and Corp Rest Adv A
JIREX12.120.03
+0.25%
JHancock Real Estate Securities 1
BAFHX18.050.03
+0.17%
Brown Advisory WMC Strat Eurp Eq Instl